Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Nasal Spray Recalled Due to Bacterial Contamination

By MaryBeth DiDonna | August 10, 2018

The FDA has cautioned against using a specific type of CVS nasal spray, due to Pseudomonas aeruginosa, a common Gram-negative, rod-shaped bacterium that can cause disease in humans. The FDA notes that those who use the product and suffer from cystic fibrosis or are immuno-compromised are at particular risk, although the agency also states that they have not yet received any reports of adverse events from the spray.

There has been a voluntary recall of Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid used as a nasal decongestant. Consumers are encouraged to stop using the product and either bring it back to CVS or throw it away.

The CDC has also issued a warning that  Pseudomonas aeruginosa can sicken otherwise healthy people after exposure to water. Children are at particular risk for ear infections after being in inadequately chlorinated swimming pools, and more generalized skin rashes can occur in people who are exposed to both inadequately chlorinated swimming pools and hot tubs.

People who use extended-wear contact lenses may also be at risk for eye infections due to the bacteria. Patients in hospitals — particularly those on breathing machines, using devices such as catheters, and with wounds from surgery or burns — are also at partially risk for serious, potentially life-threatening infections.

Proper hand hygiene and environmental cleaning is crucial to prevent the spread of disease resulting from Pseudomonas aeruginosa, as is avoiding improperly maintained pools and hot tubs. P. aeruginosa infections are typically treated with antibiotics, though increasing antibiotic-resistance of course poses a problem.

Related Articles Read More >

As AI floods drug discovery with designs, Twist uses DNA chips to tackle the wet-lab bottleneck
Business, Finance and Investment, data analysis concept. Business woman using calculator to calculate financial report and analyzing market data, business planning, market research
The NIH tried to make research more accessible, researchers are paying the price
MBARI's Monterey Accelerated Research System (MARS) connects seafloor instruments to shore through a roughly 51-kilometer power and fiber-optic cable (red line) ending at a node about 891 meters down. The Geo-Sense system described in the new paper takes the opposite approach: a portable, battery-powered cable that records locally with no link to shore. Researchers used MARS's own fiber data to cross-check Geo-Sense's earthquake detections. Credit: MBARI
How lightweight AI startup Lightscline helped turn one to two years of seafloor data analysis into a two-month sprint
Interphex 2026 awards honor technologies focused on flexibility, automated workflows and ease of use
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE